Abstract
The inherited deficiency of adenosine deaminase (adenosine aminohydrolase; EC 3.5.4.4) activity in humans is associated with an immunodeficiency. Some of the immunodeficient and enzyme-deficient patients respond immunologically to periodic infusions of irradiated erythrocytes containing adenosine deaminase. It has been previously reported that erythrocytes and lymphocytes from immunodeficient ane enzyme-deficient children contained increased concentrations of ATP, and in the one child studied after erythrocyte infusion therapy, the intracellular level of ATP diminished. Using high-pressure liquid chromatography that resolves ATP and 2'-dATP, we have observed greater than 50-fold elevations of dATP in the erythrocytes of immunodeficient, adenosine deaminase-deficient patients but not in the erythrocytes of an immunocompetent adenosine deaminase-deficient patient. The erythrocyte dATP in two unrelated adenosine deaminase-deficient, immunodeficient patients disappeared after infusion of normal erythrocytes. We propose that deoxyadenosine, a substrate of adenosine deaminase, is the potentially toxic substrate in adenosine deaminase deficiency, and that the mediator of the toxic effect is dATP, a recognized potent inhibitor of ribonucleotide reductase.
Full text
PDF![472](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492c/411272/e5fd313e15c1/pnas00013-0477.png)
![473](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492c/411272/90c2cca4a0de/pnas00013-0478.png)
![474](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492c/411272/e64c433fbf29/pnas00013-0479.png)
![475](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492c/411272/de31f85c3878/pnas00013-0480.png)
![476](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492c/411272/95bd9efb6308/pnas00013-0481.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ackeret C., Llüss H. J., Hitzig W. H. Hereditary sever combined immunodeficiency and adenosine deaminase deficiency. Pediatr Res. 1976 Jan;10(1):67–70. doi: 10.1203/00006450-197601000-00013. [DOI] [PubMed] [Google Scholar]
- Agarwal R. P., Crabtree G. W., Parks R. E., Jr, Nelson J. A., Keightley R., Parkman R., Rosen F. S., Stern R. C., Polmar S. H. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency. J Clin Invest. 1976 Apr;57(4):1025–1035. doi: 10.1172/JCI108344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Agarwal R. P., Sagar S. M., Parks R. E., Jr Adenosine deaminase from human erythrocytes: purification and effects of adenosine analogs. Biochem Pharmacol. 1975 Mar 15;24(6):693–701. doi: 10.1016/0006-2952(75)90245-2. [DOI] [PubMed] [Google Scholar]
- BELTZ R. E. Comparison of the content of thymidylate synthetase, deoxycytidylate deaminase and deoxyribonucleoside kinase in normal and regenerating rat liver. Arch Biochem Biophys. 1962 Nov;99:304–312. doi: 10.1016/0003-9861(62)90015-2. [DOI] [PubMed] [Google Scholar]
- Benke P. J., Dittmar D. Purine dysfunction in cells from patients with adenosine deaminase deficiency. Pediatr Res. 1976 Jul;10(7):642–646. doi: 10.1203/00006450-197607000-00002. [DOI] [PubMed] [Google Scholar]
- Blume A. J., Dalton C., Sheppard H. Adenosine-mediated elevation of cyclic 3':5'-adenosine monophosphate concentrations in cultured mouse neuroblastoma cells. Proc Natl Acad Sci U S A. 1973 Nov;70(11):3099–3102. doi: 10.1073/pnas.70.11.3099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bär H. P., Hechter O. Substrate specificity of adenyl cyclase from rat fat cell ghosts. Biochim Biophys Acta. 1969 Oct 7;192(1):141–144. doi: 10.1016/0304-4165(69)90021-x. [DOI] [PubMed] [Google Scholar]
- Carson D. A., Kaye J., Seegmiller J. E. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci U S A. 1977 Dec;74(12):5677–5681. doi: 10.1073/pnas.74.12.5677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carson D. A., Seegmiller J. E. Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis. J Clin Invest. 1976 Feb;57(2):274–282. doi: 10.1172/JCI108278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen A., Doyle D., Martin D. W., Jr, Ammann A. J. Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med. 1976 Dec 23;295(26):1449–1454. doi: 10.1056/NEJM197612232952603. [DOI] [PubMed] [Google Scholar]
- Dissing J., Knudsen B. Adenosine-deaminase deficiency and combined immunodeficiency syndrome. Lancet. 1972 Dec 16;2(7790):1316–1316. doi: 10.1016/s0140-6736(72)92692-x. [DOI] [PubMed] [Google Scholar]
- Durham J. P., Ives D. H. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation. Mol Pharmacol. 1969 Jul;5(4):358–375. [PubMed] [Google Scholar]
- Giblett E. R., Ammann A. J., Wara D. W., Sandman R., Diamond L. K. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet. 1975 May 3;1(7914):1010–1013. doi: 10.1016/s0140-6736(75)91950-9. [DOI] [PubMed] [Google Scholar]
- Giblett E. R., Anderson J. E., Cohen F., Pollara B., Meuwissen H. J. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972 Nov 18;2(7786):1067–1069. doi: 10.1016/s0140-6736(72)92345-8. [DOI] [PubMed] [Google Scholar]
- Gilman A. G., Schrier B. K. Adenosine cyclic 3',5'-monophosphate in fetal rat brain cell cultures. I. Effect of catecholamines. Mol Pharmacol. 1972 Jul;8(4):410–416. [PubMed] [Google Scholar]
- Green H., Chan T. Pyrimidine starvation induced by adenosine in fibroblasts and lymphoid cells: role of adenosine deaminase. Science. 1973 Nov 23;182(4114):836–837. doi: 10.1126/science.182.4114.836. [DOI] [PubMed] [Google Scholar]
- Hirschhorn R., Grossman J., Weissmann G. Effect of cyclic 3',5'-adenosine monophosphate and theophylline on lymphocyte transformation. Proc Soc Exp Biol Med. 1970 Apr;133(4):1361–1365. doi: 10.3181/00379727-133-34690. [DOI] [PubMed] [Google Scholar]
- Hirschhorn R., Levytska V. Alterations in isozymes of adenosine deaminase during stimulation of human peripheral blood lymphocytes. Cell Immunol. 1974 Jun;12(3):387–395. doi: 10.1016/0008-8749(74)90095-1. [DOI] [PubMed] [Google Scholar]
- Huang M., Drummond G. I. Effect of adenosine on cyclic AMP accumulation in ventricular myocardium. Biochem Pharmacol. 1976 Dec 15;25(24):2713–2719. doi: 10.1016/0006-2952(76)90262-8. [DOI] [PubMed] [Google Scholar]
- Jenkins T., Rabson A. R., Nurse G. T., Lane A. B. Deficiency of adenosine deaminase not associated with severe combined immunodeficiency. J Pediatr. 1976 Nov;89(5):732–736. doi: 10.1016/s0022-3476(76)80792-5. [DOI] [PubMed] [Google Scholar]
- KLENOW H. Further studies on the effect of deoxyadenosine on the accumulation of deoxyadenosine triphosphate and inhibition of deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells in vitro. Biochim Biophys Acta. 1962 Dec 31;61:885–896. doi: 10.1016/0926-6550(62)90005-1. [DOI] [PubMed] [Google Scholar]
- Keightley R. G., Lawton A. R., Cooper M. D., Yunis E. J. Successful fetal liver transplantation in a child with severe combined immunodeficiency. Lancet. 1975 Nov 1;2(7940):850–853. doi: 10.1016/s0140-6736(75)90238-x. [DOI] [PubMed] [Google Scholar]
- Keith G., Gilham P. T. Stepwise degradation of polyribonucleotides. Biochemistry. 1974 Aug 13;13(17):3601–3606. doi: 10.1021/bi00714a031. [DOI] [PubMed] [Google Scholar]
- Kolassa N., Pfleger K. Adenosine uptake by erythrocytes of man, rat and guinea-pig and its inhibition by hexobendine and dipyridamole. Biochem Pharmacol. 1975 Jan 1;24(1):154–156. doi: 10.1016/0006-2952(75)90331-7. [DOI] [PubMed] [Google Scholar]
- Krenitsky T. A., Tuttle J. V., Koszalka G. W., Chen I. S., Beacham L. M., 3rd, Rideout J. L., Elion G. B. Deoxycytidine kinase from calf thymus. Substrate and inhibitor specificity. J Biol Chem. 1976 Jul 10;251(13):4055–4061. [PubMed] [Google Scholar]
- MUNCH-PETERSEN A. Formation in vitro of deoxyadenosine triphosphate from deoxyadenosine in Ehrlich ascites cells. Biochem Biophys Res Commun. 1960 Oct;3:392–396. doi: 10.1016/0006-291x(60)90051-6. [DOI] [PubMed] [Google Scholar]
- Martin D. W., Jr, Owen N. T. Repression and derepression of purine biosynthesis in mammalian hepatoma cells in culture. J Biol Chem. 1972 Sep 10;247(17):5477–5485. [PubMed] [Google Scholar]
- Meuth M., Green H. Alterations leading to increased ribonucleotide reductase in cells selected for resistance to deoxynucleosides. Cell. 1974 Dec;3(4):367–374. doi: 10.1016/0092-8674(74)90052-x. [DOI] [PubMed] [Google Scholar]
- Meyers M. B., Kreis W. Purification of deoxycytidine kinases from two P815 murine neoplasms and their separation from deoxyguanosine kinase. Arch Biochem Biophys. 1976 Nov;177(1):10–15. doi: 10.1016/0003-9861(76)90409-4. [DOI] [PubMed] [Google Scholar]
- Mills G. C., Schmalstieg F. C., Trimmer K. B., Goldman A. S., Goldblum R. M. Purine metabolism in adenosine deaminase deficiency. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2867–2871. doi: 10.1073/pnas.73.8.2867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moore E. C., Hurlbert R. B. Regulation of mammalian deoxyribonucleotide biosynthesis by nucleotides as activators and inhibitors. J Biol Chem. 1966 Oct 25;241(20):4802–4809. [PubMed] [Google Scholar]
- Nordenskjöld B. A., Skoog L., Brown N. C., Reichard P. Deoxyribonucleotide pools and deoxyribonucleic acid synthesis in cultured mouse embryo cells. J Biol Chem. 1970 Oct 25;245(20):5360–5368. [PubMed] [Google Scholar]
- Nuki G., Astrin K., Brenton D., Cruikshank M., Lever J., Seegmiller J. E. Purine and pyrimidine nucleotide concentrations in cells with decreased hypoxanthine-guanine-phosphoribosyltransferase (HGPRT) activity. Adv Exp Med Biol. 1977;76A:326–340. doi: 10.1007/978-1-4613-4223-6_41. [DOI] [PubMed] [Google Scholar]
- Parkman R., Gelfand E. W., Rosen F. S., Sanderson A., Hirschhorn R. Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med. 1975 Apr 3;292(14):714–719. doi: 10.1056/NEJM197504032921402. [DOI] [PubMed] [Google Scholar]
- Polmar S. H., Stern R. C., Schwartz A. L., Wetzler E. M., Chase P. A., Hirschhorn R. Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med. 1976 Dec 9;295(24):1337–1343. doi: 10.1056/NEJM197612092952402. [DOI] [PubMed] [Google Scholar]
- Polmar S. H., Wetzler E. M., Stern R. C., Hirschhorn R. Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency. Lancet. 1975 Oct 18;2(7938):743–746. doi: 10.1016/s0140-6736(75)90726-6. [DOI] [PubMed] [Google Scholar]
- Schmalstieg F. C., Nelson J. A., Mills G. C., Monahan T. M., Goldman A. S., Goldblum R. M. Increased purine nucleotides in adenosine deaminase-deficient lymphocytes. J Pediatr. 1977 Jul;91(1):48–51. doi: 10.1016/s0022-3476(77)80442-3. [DOI] [PubMed] [Google Scholar]
- Snyder F. F., Seegmiller J. E. The adenosine-like effect of exogenous cyclic AMP upon nucleotide and PP-ribose-P concentrations of cultured human lymphoblasts. FEBS Lett. 1976 Jul 1;66(1):102–106. doi: 10.1016/0014-5793(76)80595-9. [DOI] [PubMed] [Google Scholar]
- Solter A. W., Handschumacher R. E. A rapid quantitative determination of deoxyribonucleoside triphosphates based on the enzymatic synthesis of DNA. Biochim Biophys Acta. 1969 Feb 18;174(2):585–590. doi: 10.1016/0005-2787(69)90288-3. [DOI] [PubMed] [Google Scholar]
- Tattersall M. H., Ganeshaguru K., Hoffbrand A. V. The effect of external deoxyribonucleosides on deoxyribonucleoside triphosphate concentrations in human lymphocytes. Biochem Pharmacol. 1975 Aug 15;24(16):1495–1498. doi: 10.1016/0006-2952(75)90025-8. [DOI] [PubMed] [Google Scholar]
- Ullman B., Cohen A., Martin D. W. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease. Cell. 1976 Oct;9(2):205–211. doi: 10.1016/0092-8674(76)90111-2. [DOI] [PubMed] [Google Scholar]
- Wolberg G., Zimmerman T. P., Hiemstra K., Winston M., Chu L. C. Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate. Science. 1975 Mar 14;187(4180):957–959. doi: 10.1126/science.167434. [DOI] [PubMed] [Google Scholar]
- Yount J., Nichols P., Ochs H. D., Hammar S. P., Scott C. R., Chen S. H., Giblett E. R., Wedgwood R. J. Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency. J Pediatr. 1974 Feb;84(2):173–177. doi: 10.1016/s0022-3476(74)80597-4. [DOI] [PubMed] [Google Scholar]